BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38548210)

  • 1. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
    Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
    J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
    Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
    Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
    Hashimoto K
    Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
    Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
    JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
    Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
    J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
    Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
    Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
    Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
    J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
    Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
    J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
    MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
    Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
    Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data.
    Tomasik J; Han SYS; Barton-Owen G; Mirea DM; Martin-Key NA; Rustogi N; Lago SG; Olmert T; Cooper JD; Ozcan S; Eljasz P; Thomas G; Tuytten R; Metcalfe T; Schei TS; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
    Transl Psychiatry; 2021 Jan; 11(1):41. PubMed ID: 33436544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic analysis to detect urinary molecular changes associated with bipolar depression.
    Ren Y; Chen ZZ; Sun XL; Duan HJ; Tian JS; Wang JY; Yang H
    Neurosci Lett; 2021 Jan; 742():135515. PubMed ID: 33227370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
    Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
    J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative separation of the depressive phase of bipolar disorder and major depressive disorder using electrovestibulography.
    Lithgow BJ; Moussavi Z; Fitzgerald PB
    World J Biol Psychiatry; 2019 Dec; 20(10):799-812. PubMed ID: 30912461
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis.
    Fernandes BS; Gama CS; Kauer-Sant'Anna M; Lobato MI; Belmonte-de-Abreu P; Kapczinski F
    J Psychiatr Res; 2009 Oct; 43(15):1200-4. PubMed ID: 19501841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.